Hogy Medical Co.,Ltd.
General ticker "HGYMF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $602.6M (TTM average)
Hogy Medical Co.,Ltd. follows the US Stock Market performance with the rate: 33.8%.
Estimated limits based on current volatility of 0.0%: low 34.99$, high 34.99$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.16$ (Y0.46%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [14.55$, 24.86$]
- 2026-03-31 to 2027-03-31 estimated range: [14.47$, 24.60$]
Financial Metrics affecting the HGYMF estimates:
- Positive: with PPE of 58.9 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 9.73
- Positive: Operating cash flow per share per price, % of 14.15 > 13.24
- Negative: 0.01 < Interest expense per share per price, % of 0.09
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
- Positive: -8.75 < Industry operating profit margin (median), % of -6.19
- Negative: Investing cash flow per share per price, % of -4.80 <= -4.48
Short-term HGYMF quotes
Long-term HGYMF plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 |
|---|---|---|
| Operating Revenue | ¥39,100.00MM | ¥39,138.00MM |
| Operating Expenses | ¥34,931.00MM | ¥35,328.00MM |
| Operating Income | ¥4,169.00MM | ¥3,810.00MM |
| Non-Operating Income | ¥-94.00MM | ¥-876.00MM |
| Interest Expense | ¥23.00MM | ¥70.00MM |
| R&D Expense | ¥297.00MM | ¥0.00MM |
| Income(Loss) | ¥4,075.00MM | ¥2,934.00MM |
| Taxes | ¥1,282.00MM | ¥1,413.00MM |
| Profit(Loss)* | ¥2,804.00MM | ¥1,521.00MM |
| Stockholders Equity | ¥86,110.00MM | ¥74,323.00MM |
| Assets | ¥100,041.00MM | ¥97,895.00MM |
| Operating Cash Flow | ¥7,117.00MM | ¥11,555.00MM |
| Capital expenditure | ¥2,801.00MM | ¥5,307.00MM |
| Investing Cash Flow | ¥-3,262.00MM | ¥-3,917.00MM |
| Financing Cash Flow | ¥-3,892.00MM | ¥-5,455.00MM |
| Earnings Per Share** | ¥115.54 | ¥67.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.